University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Mitchel Berger, M.D.

Chair of Neurological Surgery
Neurosurgeon

Dr. Mitchel S. Berger, chair of Neurological Surgery, is a nationally recognized expert in treating brain and spinal cord tumors and tumor-related epilepsy in adults and children. He also is a specialist in brain mapping techniques, used to identify areas of motor, sensory and language function during surgery, and an expert in the use of the Gamma Knife for tumor treatment. He is co-director of the Adult Brain Tumor Surgery Program, director of the Brain Tumor Research Center and director of the Center for Neurological Injury and Repair.

Berger, a professor of neurosurgery at UCSF, earned a bachelor's degree from Harvard College in 1975 and a medical degree from the University of Miami School of Medicine in 1979. He completed an internship and residency at UCSF and was awarded a clinical fellowship in neuro-oncology by the American Cancer Society and a research fellowship with the Brain Tumor Research Center. He completed further fellowship training in neuro-oncology at UCSF and in pediatric neurosurgery at the Hospital for Sick Children of the University of Toronto, Canada. His professional activities include his election to the board of directors of the American Association of Neurological Surgeons and his appointment to the American Board of Neurological Surgeons. Berger is board certified in neurosurgery.

Read a Q&A with Berger.

Clinics

California Center for Pituitary Disorders
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (866) 559-5543
or (415) 353-7500
Fax: (415) 353-2889

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neuro-Oncology Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-2966
Fax: (415) 353-2167

Hours: Monday to Friday
8 a.m. – 5 p.m.

Neurosurgery Clinic
400 Parnassus Ave., Eighth Floor
San Francisco, CA 94143
Phone: (415) 353-7500
Fax: (415) 353-2889

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

More about Mitchel Berger

Education

University of Miami School of Medicine 1979

Residencies

UCSF Medical Center, General Surgery 1979

Fellowships

UCSF Medical Center, Neuro-oncology 1985
Hospital for Sick Children, Toronto, Canada, Pediatric Neurological Surgery 1986

Selected Research and Publications

  1. Hervey-Jumper SL, Berger MS. In reply: reoperation for recurrent high-grade glioma: does tumor genetics play a role? Neurosurgery. 2015 Apr; 76(4):E497.
  2. Randhawa P, Pastrana DV, Zeng G, Huang Y, Shapiro R, Sood P, Puttarajappa C, Berger M, Hariharan S, Buck CB. Commercially Available Immunoglobulins Contain Virus Neutralizing Antibodies Against All Major Genotypes of Polyomavirus BK. Am J Transplant. 2015 Apr; 15(4):1014-20.
  3. van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF. Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment. Acta Neuropathol. 2015 Apr; 129(4):597-607.
  4. Barajas RF, Pampaloni MH, Clarke JL, Seo Y, Savic D, Hawkins RA, Behr SC, Chang SM, Berger M, Dillon WP, Cha S. Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma. Case Rep Radiol. 2015; 2015:731361.
  5. Rolston JD, Englot DJ, Benet A, Li J, Cha S, Berger MS. Frontal operculum gliomas: language outcome following resection. J Neurosurg. 2015 Apr; 122(4):725-34.
  6. Breshears JD, Ivan ME, Cotter JA, Bollen AW, Theodosopoulos PV, Berger MS. Primary glioblastoma of the trigeminal nerve root entry zone: case report. J Neurosurg. 2015 Jan; 122(1):78-81.
  7. Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 2015 Jan; 38(1):E6.
  8. Li N, Maly DJ, Chanthery YH, Sirkis DW, Nakamura JL, Berger MS, James CD, Shokat KM, Weiss WA, Persson AI. Radiotherapy followed by aurora kinase inhibition targets tumor-propagating cells in human glioblastoma. Mol Cancer Ther. 2015 Feb; 14(2):419-28.
  9. Berger MS, Bruce JN, Chen TC, Zadeh G. Introduction: Glioblastoma: an update on pathophysiology and management strategies. Neurosurg Focus. 2014 Dec; 37(6):Introduction.
  10. Chang EF, Raygor KP, Berger MS. Contemporary model of language organization: an overview for neurosurgeons. J Neurosurg. 2015 Feb; 122(2):250-61.
  11. Trinh VT, Davies JM, Berger MS. Surgery for primary supratentorial brain tumors in the United States, 2000-2009: effect of provider and hospital caseload on complication rates. J Neurosurg. 2015 Feb; 122(2):280-96.
  12. Hervey-Jumper SL, Berger MS. Reoperation for recurrent high-grade glioma: a current perspective of the literature. Neurosurgery. 2014 Nov; 75(5):491-9; discussion 498-9.
  13. Rolston JD, Zygourakis CC, Han SJ, Lau CY, Berger MS, Parsa AT. Medical errors in neurosurgery. Surg Neurol Int. 2014; 5(Suppl 10):S435-40.
  14. Saigal R, Berger MS. The long-term effects of repetitive mild head injuries in sports. Neurosurgery. 2014 Oct; 75 Suppl 4:S149-55.
  15. Osorio JA, Hervey-Jumper SL, Walsh KM, Clarke JL, Butowski NA, Prados MD, Berger MS. Familial gliomas: cases in two pairs of brothers. J Neurooncol. 2015 Jan; 121(1):135-40.
  16. Hervey-Jumper SL, Breshears J, Berger MS. Gelfoam scaffold for vein prolapse during brain tumor surgery. World Neurosurg. 2014 Nov; 82(5):912.e11-3.
  17. Zygourakis CC, Sughrue ME, Benet A, Parsa AT, Berger MS, McDermott MW. Management of planum/olfactory meningiomas: predicting symptoms and postoperative complications. World Neurosurg. 2014 Dec; 82(6):1216-23.
  18. Foret MR, Sandstrom RS, Rhodes CT, Wang Y, Berger MS, Lin CH. Molecular targets of chromatin repressive mark H3K9me3 in primate progenitor cells within adult neurogenic niches. Front Genet. 2014; 5:252.
  19. Saigal R, Batjer HH, Ellenbogen RG, Berger MS. Return to play for neurosurgical patients. World Neurosurg. 2014 Sep-Oct; 82(3-4):485-91.
  20. Sandstrom RS, Foret MR, Grow DA, Haugen E, Rhodes CT, Cardona AE, Phelix CF, Wang Y, Berger MS, Lin CH. Epigenetic regulation by chromatin activation mark H3K4me3 in primate progenitor cells within adult neurogenic niche. Sci Rep. 2014; 4:5371.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.